EGFR and neoplasm: Collectively, from the aforementioned observations, as well as previous findings that the tumors undergo drug-induced phenotype switching while maintaining their primary mutations in EGFR, one can conclude that tumor cell plasticity-induced EMT is essential for acquired resistance upon multiple TKIs treatment, during which there are no genetic alterations.